And their results have been mixed
Whether patients progress in diabetic retinopathy or not, I would rather we potentially ameliorate their macrovascular risk of cardiovascular and cerebrovascular diseases, instead of worrying about microvascular, eye-related risks that we can manage appropriately with current modalities. New Indication, New Patients
7 Causes of Weight Loss Plateaus on GLP-1 Medications Hitting a weight loss plateau on GLP-1 medications like Semaglutide or Wegovy is common and temporary
It's time to love the way you look
Clinical studies show that people using tirzepatide can lose a significant amount of weight over time, often averaging 15% to 22% of their body weight after about a year, depending on the dose and individual factors
Primary outcomes included cataracts, oculomotor binocular dysfunction, visual disturbances, dry eye disease, ametropic accommodative dysfunction, and visual issues with blindness, assessed through Cox proportional hazards models with Bonferroni correction